Orthofix Medical Inc. (OFIX)
The company now
Orthofix Medical Inc. reported second quarter 2026 net sales of $210.9 million on 5 August 2026, up 3.8 percent on the year before 2. The net loss for the quarter was $15.8 million 2.
The company raised its full-year 2026 guidance and now expects net sales of $845 million to $855 million 2. It tied the raise to the restoration of Medicare payment for bone growth stimulators and to second quarter results 2.
Chief executive Massimo Calafiore said the restoration of Medicare payment removes a meaningful headwind for the second half, while calling the transformation a work in progress 2.
Cash fell to $104.4 million on 30 June 2026 from $120.9 million on 31 March 2026, because of arbitration award and settlement payments to three former executives terminated in 2023 2.
As of Oct 28, 2026. Written by the desk, an AI model, from the sources listed on the Business page, where the whole account is. Nothing here is advice.
Newer filings are on file since this was written; an update is queued.